Similar articles for PMID: 20551248

Year	Number of Results
2004	2
2005	3
2006	9
2007	9
2008	10
2009	10
2010	10
2011	4
2012	1
2013	2
2014	3
2015	3
2019	1
2023	1

1

Weidle UH, Scheuer W, Eggle D, Klostermann S, Stockinger H. Weidle UH, et al. Cancer Genomics Proteomics. 2010 May-Jun;7(3):157-69. Cancer Genomics Proteomics. 2010. PMID: 20551248 Review.

2

The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.

Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F. Pinheiro C, et al. Eur J Cancer. 2009 Sep;45(13):2418-24. doi: 10.1016/j.ejca.2009.06.018. Epub 2009 Jul 21. Eur J Cancer. 2009. PMID: 19628385

3

Expression and clinical significance of CD147 in genitourinary carcinomas.

Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD. Han ZD, et al. J Surg Res. 2010 May 15;160(2):260-7. doi: 10.1016/j.jss.2008.11.838. Epub 2008 Dec 10. J Surg Res. 2010. PMID: 19286191

4

CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.

Schneiderhan W, Scheler M, Holzmann KH, Marx M, Gschwend JE, Bucholz M, Gress TM, Seufferlein T, Adler G, Oswald F. Schneiderhan W, et al. Gut. 2009 Oct;58(10):1391-8. doi: 10.1136/gut.2009.181412. Epub 2009 Jun 7. Gut. 2009. PMID: 19505879

5

Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.

Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Nabeshima K, et al. Pathol Int. 2006 Jul;56(7):359-67. doi: 10.1111/j.1440-1827.2006.01972.x. Pathol Int. 2006. PMID: 16792544 Review.

6

A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.

Su J, Chen X, Kanekura T. Su J, et al. Cancer Lett. 2009 Jan 8;273(1):140-7. doi: 10.1016/j.canlet.2008.07.034. Epub 2008 Sep 7. Cancer Lett. 2009. PMID: 18778892

7

CD147/basigin promotes progression of malignant melanoma and other cancers.

Kanekura T, Chen X. Kanekura T, et al. J Dermatol Sci. 2010 Mar;57(3):149-54. doi: 10.1016/j.jdermsci.2009.12.008. Epub 2010 Jan 8. J Dermatol Sci. 2010. PMID: 20060267 Review.

8

Epitope mapping of series of monoclonal antibodies against the hepatocellular carcinoma-associated antigen HAb18G/CD147.

Ku XM, Liao CG, Li Y, Yang XM, Yang B, Yao XY, Wang L, Kong LM, Zhao P, Chen ZN. Ku XM, et al. Scand J Immunol. 2007 May;65(5):435-43. doi: 10.1111/j.1365-3083.2007.01930.x. Scand J Immunol. 2007. PMID: 17444954 Free article.

9

Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.

Baba M, Inoue M, Itoh K, Nishizawa Y. Baba M, et al. Biochem Biophys Res Commun. 2008 Sep 12;374(1):111-6. doi: 10.1016/j.bbrc.2008.06.122. Epub 2008 Jul 9. Biochem Biophys Res Commun. 2008. PMID: 18616931

10

HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.

Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM, Mi L, Wen N, Tian R, Wang L, Yao H, Feng Q, Zhang Y, Xing JL, Zhu P, Chen ZN. Xu J, et al. Mol Cancer Res. 2007 Jun;5(6):605-14. doi: 10.1158/1541-7786.MCR-06-0286. Mol Cancer Res. 2007. PMID: 17579119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed